Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Finegold

Showing results (81-90 of 488) with videos related to

Pageof 49
Sort By:
Cleveland Clinic Quarterly|January 1, 1975
Anaerobic pleuropulmonary infections. Clinical considerationsS M Finegold, J G Bartlett
European Journal of Clinical Microbiology|August 1, 1987
Comparative in vitro activity of the new macrolide A-56268 against anaerobic bacteriaH M Wexler, S M Finegold
Clinical Therapeutics|January 1, 1990
Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis groupH M Wexler, S M Finegold
Journal of Clinical Microbiology|March 1, 1979
Isolation of Legionella pneumophila from a transtracheal aspirateP H Edelstein, S M Finegold
The Journal of Infectious Diseases|December 1, 1971
Susceptibility of gram-negative anaerobic bacilli to gentamicin and other aminoglycosidesS M Finegold, V L Sutter
The Journal of Infectious Diseases|July 1, 1972
Bactericidal activity of five antimicrobial agents against Bacteroides fragilisL J Nastro, S M Finegold
Infection and Immunity|July 1, 1979
Purification and characterization of Clostridium difficile toxinR D Rolfe, S M Finegold
The American Journal of Clinical Nutrition|October 1, 1978
Fecal flora in different populations, with special reference to dietS M Finegold, V L Sutter
Chest|April 1, 1982
Bacterial infections of the lungW L George, S M Finegold
Antimicrobial Agents and Chemotherapy|April 1, 1988
In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteriaH M Wexler, S M Finegold
Pageof 49

Showing results (81-90 of 488) with videos related to

Sort By:
Pageof 49
Cleveland Clinic Quarterly|January 1, 1975
Anaerobic pleuropulmonary infections. Clinical considerationsS M Finegold, J G Bartlett
European Journal of Clinical Microbiology|August 1, 1987
Comparative in vitro activity of the new macrolide A-56268 against anaerobic bacteriaH M Wexler, S M Finegold
Clinical Therapeutics|January 1, 1990
Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis groupH M Wexler, S M Finegold
Journal of Clinical Microbiology|March 1, 1979
Isolation of Legionella pneumophila from a transtracheal aspirateP H Edelstein, S M Finegold
The Journal of Infectious Diseases|December 1, 1971
Susceptibility of gram-negative anaerobic bacilli to gentamicin and other aminoglycosidesS M Finegold, V L Sutter
The Journal of Infectious Diseases|July 1, 1972
Bactericidal activity of five antimicrobial agents against Bacteroides fragilisL J Nastro, S M Finegold
Infection and Immunity|July 1, 1979
Purification and characterization of Clostridium difficile toxinR D Rolfe, S M Finegold
The American Journal of Clinical Nutrition|October 1, 1978
Fecal flora in different populations, with special reference to dietS M Finegold, V L Sutter
Chest|April 1, 1982
Bacterial infections of the lungW L George, S M Finegold
Antimicrobial Agents and Chemotherapy|April 1, 1988
In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteriaH M Wexler, S M Finegold
Pageof 49